Company / Revenue per Share
Vericel Revenue per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$5.57
FY2025
5-year range
$2.57 / $5.57
FY2021-FY2025
Trend
+12.2%
vs FY2024
Sector context
#64 of 154
Health Care
What the data says
At $5.57, Vericel's revenue per share ranks #64 of 154 in the Health Care sector. Revenue per Share has increased for 6 consecutive years, from $1.47 in FY2019 to $5.57 in FY2025.
Based on SEC 10-K filings.
5.57 in FY2025 with a 5-year CAGR of +22.4%.
Improved from $4.18 to $5.57 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- +28.1%
- 5-Year CAGR
- +22.4%
- 10-Year CAGR
- -
Sector benchmark
#64 of 154 in Health CareTop 42% of 154This company $5.57 Sector average $15.09
▼
-63.1% below sector average
Key checks
Key Insights
- Vericel's revenue per share has grown for 6 consecutive years.
- In FY2025, revenue per share increased 12.2% year-over-year.
- Ranks #64 out of 154 companies in the Health Care sector.
- Lowest revenue per share in the period was in FY2019.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.57 | +12.2% |
| FY2024 | $4.96 | +18.7% |
| FY2023 | $4.18 | +57.8% |
| FY2022 | $2.65 | +3.0% |
| FY2021 | $2.57 | +27.0% |
| FY2020 | $2.03 | +38.1% |
| FY2019 | $1.47 | -3.3% |
| FY2018 | $1.52 | -6.4% |
| FY2017 | $1.62 | -24.7% |
| FY2016 | $2.15 | +269171.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026